HG-32USE OF KETOGENIC DIET AS A COMPLIMENTARY METABOLIC THERAPY DURING CHEMO-RADIATION THERAPY IN A 7 YEAR OLD FEMALE WITH GLIOBLASTOMA

Violet Shen(Ruhr University Bochum), Jessica Brown(Children's Hospital of Orange County), Lily Tran(Children's Hospital of Orange County)

Neuro-Oncology

June 1, 2016

10.1093/neuonc/now073.29

Cited by 5

Related Papers

Phase II Study of Clofarabine in Pediatric Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia

|Journal of Clinical Oncology|2006|309

Efficacy and safety of rasburicase, a recombinant urate oxidase (Elitek™), in the management of malignancy-associated hyperuricemia in pediatric and adult patients: final results of a multicenter compassionate use trial

|Leukemia|2004|183

Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemia

|Blood|2011|122

Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly‐diagnosed with central nervous system atypical teratoid/rhabdoid tumors: The head start III experience

|Pediatric Blood & Cancer|2013|110

Differential mechanisms in the regulation of endogenous levels of thrombopoietin and interleukin-11 during thrombocytopenia: insight into the regulation of platelet production

|Blood|1996|109